JP2015507007A5 - - Google Patents

Download PDF

Info

Publication number
JP2015507007A5
JP2015507007A5 JP2014557606A JP2014557606A JP2015507007A5 JP 2015507007 A5 JP2015507007 A5 JP 2015507007A5 JP 2014557606 A JP2014557606 A JP 2014557606A JP 2014557606 A JP2014557606 A JP 2014557606A JP 2015507007 A5 JP2015507007 A5 JP 2015507007A5
Authority
JP
Japan
Prior art keywords
patent document
russian
document
application publication
prior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014557606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015507007A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/025070 external-priority patent/WO2013122575A2/en
Publication of JP2015507007A publication Critical patent/JP2015507007A/ja
Publication of JP2015507007A5 publication Critical patent/JP2015507007A5/ja
Pending legal-status Critical Current

Links

JP2014557606A 2012-02-14 2012-02-14 抗ウイルス性の特性を有する小分子 Pending JP2015507007A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/025070 WO2013122575A2 (en) 2012-02-14 2012-02-14 Small molecule having antiviral properties

Publications (2)

Publication Number Publication Date
JP2015507007A JP2015507007A (ja) 2015-03-05
JP2015507007A5 true JP2015507007A5 (enExample) 2015-04-16

Family

ID=48984871

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014557606A Pending JP2015507007A (ja) 2012-02-14 2012-02-14 抗ウイルス性の特性を有する小分子

Country Status (3)

Country Link
EP (1) EP2819517A2 (enExample)
JP (1) JP2015507007A (enExample)
WO (1) WO2013122575A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015016818A1 (en) * 2013-07-29 2015-02-05 Ghias Asghar Novel azolo-1,2,4-triazine derived antiviral oral therapeutic
US20190211024A1 (en) * 2016-08-19 2019-07-11 General Research Laboratory Small molecules having antiviral properties

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405619A (en) * 1981-09-02 1983-09-20 Diamond Shamrock Corporation Antiinflammatory substituted-1,2,4-triazolo[4,3-b]-1,2,4-triazines
AR042052A1 (es) * 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas
KR20070085433A (ko) * 2004-11-24 2007-08-27 노파르티스 아게 Jak 저해제들과 bcr-abl, flt-3, fak 또는raf 키나제 저해제들 중 하나 이상의 조합물
RU2294936C1 (ru) * 2005-06-29 2007-03-10 Государственное Образовательное Учреждение Высшего Профессионального Образования Уральский Государственный Технический Университет-УПИ Натриевая соль 2-метилтио-6-нитро-1,2-4-триазоло[5,1-c]-1,2,4-триазин-7(4h)-она, дигидрат, обладающая противовирусной активностью
EP2094696B1 (en) * 2006-11-23 2010-10-13 Novartis AG 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists
RU2343154C2 (ru) * 2007-01-31 2009-01-10 Общество с ограниченной ответственностью Научно-техническое предприятие "Лиганд" СПОСОБ ПОЛУЧЕНИЯ НАТРИЕВОЙ СОЛИ 2-МЕТИЛТИО-6-НИТРО-1,2,4-ТРИАЗОЛО[5,1-c]-1,2,4-ТРИАЗИН-7-ОНА, ДИГИДРАТА
RU2345080C2 (ru) * 2007-02-16 2009-01-27 ГОУ ВПО Уральский государственный технический университет-УПИ 4-(4'-ГИДРОКСИБУТИЛ)-6-ФЕНИЛ-1,2,4-ТРИАЗОЛО[5,1-c][1,2,4]ТРИАЗИН-7-ОН
RU2376307C1 (ru) * 2008-05-27 2009-12-20 Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук 4-((Z)-4'-ГИДРОКСИБУТЕН-2'-ИЛ)-2-R-6-ФЕНИЛ-1,2,4-ТРИАЗОЛО[5,1-c][1,2,4]ТРИАЗИН-7-ОНЫ

Similar Documents

Publication Publication Date Title
JP2014528601A5 (enExample)
JP2014513484A5 (enExample)
JP2013517798A5 (enExample)
JP2014519662A5 (enExample)
JP2014513356A5 (enExample)
JP2014519854A5 (enExample)
JP2013540293A5 (enExample)
JP2017515162A5 (enExample)
JP2013519136A5 (enExample)
CY1119927T1 (el) Ενωσεις αργιλιου για χρηση σε θεραπευτικα μεσα και εμβολια
JP2014520155A5 (enExample)
JP2014533241A5 (enExample)
JP2013506057A5 (enExample)
JP2014532727A5 (enExample)
JP2012074699A5 (enExample)
DOP2013000029A (es) Anticuerpos peptidicos beta amiloide anti-n3pglu y usos de los mismos
JP2011219478A5 (enExample)
JP2014510857A5 (enExample)
CN106661570A8 (zh) 通过与氨甲蝶呤选择偶联的睡美人转座子制备工程化t细胞
JP2016506003A5 (enExample)
BR112013020265A2 (pt) formas de rifaximina e uso das mesmas
JP2016506890A5 (enExample)
JP2013529804A5 (enExample)
JP2019514354A5 (enExample)
BRPI0811499A2 (pt) Métodos para purificar um vírus ou antígeno viral, e para preparar uma vacina contra um vírus ou antígeno viral.